Sentences with phrase «leading cancer hospitals»

For example, in 2003 the Christie Hospital in Manchester, one of the UK's leading cancer hospitals, said it might be forced to ration future treatment due to a lack of funds.

Together with the research and clinical resources of the nation's leading cancer hospital, we have the ability to take a program from a research hypothesis all the way to a clinical candidate supported by robust preclinical data, and into early phase clinical studies in well - defined patient populations.

Not exact matches

Their scientific advisory council consists of a number of experts from leading medical institutions, including Memorial Sloan Kettering Cancer Center, New York Presbyterian Hospital's Weill - Cornell Medical Center and Duke University Medical Center.

About MaRS Innovation MaRS Innovation is the commercialization agent for Ontario's exceptional discovery pipeline from 15 leading academic institutions, including Baycrest Centre for Geriatric Care, Centre for Addiction and Mental Health, Holland Bloorview Kids Rehabilitation Hospital, The Hospital for Sick Children (SickKids), MaRS Discovery District, Mount Sinai Hospital, Ontario Institute for Cancer Research, St. Michael's Hospital, Ryerson University, Sunnybrook Health Sciences Centre, Thunder Bay Regional Research Institute, University Health Network, University of Toronto, Women's College Hospital and York University.

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

It was estimated that deaths in hospitals by preventable adverse events exceed the amount attributable to the eight leading cause of death in American (CDC, 1999b) and even exceed the number of deaths cause by automobile accidents (43,458), breast cancer (42,297) or AIDS (16,516)(CDC, 1999a).

The breast surgery and reconstructive team at The Valley Hospital in Ridgewood, NJ, is taking the lead in providing new and progressive advances in breast cancer surgery.

Researchers led by Patricia Donahoe and Xiaolong Wei of Massachusetts General Hospital and Harvard Medical School found that the common chemotherapy agent doxorubicin actually encourages the growth of ovarian cancer stem cells.

These genetic mutations can fluctuate over time, and some patients can harbor more than one mutation,» said Zofia Piotrowska, MD, lead author of the study and a thoracic oncologist at the Massachusetts General Hospital Cancer Center in Boston.

Led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in tumor cells might predict patients» response to radiation therapy.

An experimental drug in early development for aggressive brain tumors can cross the blood - brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

A team led by Lu You, an oncologist at Sichuan University's West China Hospital in Chengdu, plans to start testing such cells in people with lung cancer next month.

«Cardiac monitors constitute the majority of alarms throughout the hospital,» says Christopher Dandoy, MD, a physician in the Cancer and Blood Diseases Institute at Cincinnati Children's and lead author of the study.

Professor Nigel Bundred, from The University of Manchester and University Hospital of South Manchester NHS Foundation Trust, who led the study, said: «We know that different subtypes of invasive breast cancer have different levels of disease recurrence.

The study was led by Dr. Alexandre Zlotta, Director of Uro - Oncology at Mount Sinai Hospital, and researcher with the Lunenfeld - Tanenbaum Research Institute, part of Sinai Health System in Toronto, Canada, and Dr. Paul Boutros, Principal Investigator, Informatics and Bio-computing, Ontario Institute for Cancer Research (OICR).

The research team, led by senior author Timothy P. Cripe, MD, PhD, chief of the Division of Hematology / Oncology / BMT at Nationwide Children's Hospital, found that virotherapy doesn't always require a strong virus infection of cancer cells to cause tumors to shrink or die.

«This is the first large prospective multicenter study that was specifically constructed to look at the relationship between sleep apnea and a specific cancer,» said lead author Miguel Ángel Martinez - Garcia, MD, PhD, from the Hospital Universitario y Politécnico La Fe, Valencia, Spain.

A study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an abnormal metabolic pathway that drives cancer - cell growth in a particular glioblastoma suCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an abnormal metabolic pathway that drives cancer - cell growth in a particular glioblastoma suCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an abnormal metabolic pathway that drives cancer - cell growth in a particular glioblastoma sucancer - cell growth in a particular glioblastoma subtype.

«The phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, freePSA and p2PSA) as part of a sophisticated algorithm to more reliably determine the probability of cancer in patients with elevated PSA levels,» said Kevin Slawin, MD, director, Vanguard Urologic Institute at Memorial Hermann Medical Group, clinical professor of Urology at Baylor College of Medicine and director of Urology, Memorial Hermann Hospital ‐ Texas Medical Center, who performed some of the key research that led to the development of the phi test and who also began using the test in February.

A new study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) reveals details about how such viral DNA insertion complexes hunt for a suitable spot and how quickly insertion happens at the chosen site.

«These findings give us reason to rethink how we manage prostate cancer in men with known heart disease,» said Anthony D'Amico, MD, lead author of the research paper and chief of genitourinary radiation oncology at Brigham and Women's Hospital..

«A deeper analysis of the primary tumor may be all we need to prevent metastases,» said UNC Lineberger's Lisa A. Carey, MD, physician - in - chief of the N.C. Cancer Hospital and the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, who leads the Tumor Donation Program.

Researchers led by Kathryn Wilson from Brigham and Women's Hospital and the Harvard T. H. Chan School of Public Health, both in Boston, had combed through data from two longitudinal studies to identify 575 individuals who had gone on to develop kidney cancer.

A research group at Boston's Massachusetts General Hospital, led by Tayyaba Hasan, has used nanocells and photodynamic therapy (light - activated chemicals) to target pancreatic cancer.

The preclinical study was led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

For the current study, scientists led by Helmneh Sineshaw, M.D., MPH, analyzed data from 260,174 breast cancer cases recorded in the National Cancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer Socancer cases recorded in the National Cancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer SoCancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer Socancer registry database jointly sponsored by the American College of Surgeons and the American Cancer SoCancer Society.

The researchers, at St. Jude Children's Research Hospital in Memphis, Tennessee, and Washington University in St. Louis in Missouri, and led by pediatric researcher and St. Jude's CEO James Downing, hunted for dangerous genes in 1120 cancer patients under the age of 20.

Upon graduating with her master's in genetic counseling, which she completed alongside her clinical training, Kenwrick took a position as a genetic counselor with the East Anglian Clinical Genetics Service at Addenbrooke's Hospital in Cambridge, where she now leads the cancer genetics counseling service.

In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutacancer patients with B - raf mutations.

Dr. Cooper joined MDACC in 2006 as section chief of cell therapy at the Children's Cancer Hospital, where he cared for children undergoing bone marrow transplantation and led scientific efforts to develop new treatment approaches that pair genetic engineering with immunotherapies.

«Liver cancer is the second leading cause of cancer death worldwide, and HBV is the most prevalent risk factor in our region, says Teng ‐ Yu Lee, MD, PhD, a researcher in the Department of Gastroenterology at Taichung Veterans General Hospital and lead investigator in the study.

In a letter published in the cancer journal Annals of Oncology, researchers led by Professor Jean - Philippe Spano, head of the medical oncology department at Pitie - Salpetriere Hospital AP - HP in Paris, France, report that while treating an HIV - infected lung cancer patient with the cancer drug nivolumab, they observed a «drastic and persistent decrease» in the reservoirs of cells in the body where the human immunodeficiency virus (HIV) is able to hide away from attack by anti-retroviral therapy.

«The integration of palliative care, as a necessary and essential component of cancer care, is one that has been increasingly endorsed,» said Richard Riedel, M.D., lead author of the Duke study and medical director of Duke University Hospital's solid tumor inpatient service.

By combining two modalities of imaging, investigators from Norris Cotton Cancer Center at Dartmouth, led by Keith Paulsen, PhD with first author Michael Mastanduno and collaborators from Xijing Hospital in Xian, China, demonstrated that a dual breast exam using MRI and Near Infrared Spectral Tomography (NIRST) is feasible and more accurate than MRI alone.

«Elderly individuals, those ages 75 and older, account for approximately 40 percent of patients diagnosed with pancreatic cancer,» says study lead author Raphael Yechieli, M.D., with the Department of Radiation Oncology at Henry Ford Hospital.

The researchers, led by Professor Bernd Pichler at the Werner Siemens Imaging Center, worked with dermatologists, pathologists and immunologists at the University hospitals and at the German Consortium for Translational Cancer Research.

«Cardiovascular disease is the most common cause of death in women, almost three times more common than breast cancer,» says the study's lead author, Associate Professor Michael d'Emden of the Royal Brisbane Hospital.

The research, led by Daniel Krauss, M.D., a radiation oncologist, Beaumont Hospital — Royal Oak, found an association between positive post-radiation therapy biopsy results and subsequent clinical outcomes in men with localized prostate cancer.

The quest to improve survival of children with a high - risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other cancers.

Either drink delivers a sugar shot that increases insulin and insulinlike growth factor, «both of [which] promote inflammation and both lead to cancer cell division,» says Abrams, who is also professor of clinical medicine at U.C.S.F., and chief of hematotology / oncology at San Francisco General Hospital.

The altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — Jcancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — JCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — JCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

Nicolas Faris, MDiv and Raymond Osarogiagbon, MBBS led a group of researchers from Baptist Cancer Center and the University of Memphis in Tennessee, who reviewed hospital records for all patients who underwent surgery for suspected lung cancer at Baptist Memorial Hospital between January 2009 and JuneCancer Center and the University of Memphis in Tennessee, who reviewed hospital records for all patients who underwent surgery for suspected lung cancer at Baptist Memorial Hospital between January 2009 and Juhospital records for all patients who underwent surgery for suspected lung cancer at Baptist Memorial Hospital between January 2009 and Junecancer at Baptist Memorial Hospital between January 2009 and JuHospital between January 2009 and June 2013.

A new study led by scientists at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently used to treat heart, vascular and kidney disorders — can be safely used in cancer treatment to curb the growth of blood vessels in tCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently used to treat heart, vascular and kidney disorders — can be safely used in cancer treatment to curb the growth of blood vessels in tCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) suggests that dopamine — an inexpensive drug currently used to treat heart, vascular and kidney disorders — can be safely used in cancer treatment to curb the growth of blood vessels in tcancer treatment to curb the growth of blood vessels in tumors.

«We are very excited with the outcome of this work,» said lead author Simone Treiger Sredni, MD, PhD, Associate Professor of Pediatric Neurosurgery at Northwestern University Feinberg School of Medicine and cancer researcher at the Stanley Manne Children's Research Institute of Ann & Robert H. Lurie Children's Hospital of Chicago.

Patients with incurable cancer and numerous other serious health conditions who consulted with a palliative care team within two days of hospitalization had significant savings in hospital costs, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.

An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve - Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T - cells of the immune system to react against foreign antigens and cancer.

CRI establishes the Veterinary Cancer Unit, led by William D. Hardy Jr., at the ASPCA Hospital, to deal with questions of leukemia and other cancers in animals.

He was led to hospital records at the New York Hospital where he pored through past case histories until he found something interesting: the case of a patient named Stein, a German immigrant who had been treated with surgery for a cancer very similar to Bhospital records at the New York Hospital where he pored through past case histories until he found something interesting: the case of a patient named Stein, a German immigrant who had been treated with surgery for a cancer very similar to BHospital where he pored through past case histories until he found something interesting: the case of a patient named Stein, a German immigrant who had been treated with surgery for a cancer very similar to Bessie's.

St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life - threatening diseases.

April 2, 2018 - Mullally leads a research laboratory at Brigham and Women's Hospital, where her team investigates the biology and treatment of blood cancers.